Type B dissection.
It is accepted that the prognosis and outcomes of type B dissection are more favourable if the false lumen is thrombosed. According to Roger Greenhalgh, chairman of the CX Programme Organising Board, this has been taken by some vascular specialists to imply that the false lumen should be embolised, if it is not thrombosed, and intervention will provide a better prognosis. “This is a very controversial area,” he says; therefore, CX will hold a Mini-symposium on the topic.
The Mini-symposium, which is part of the Thoracic Aortic Aneurysm Challenges Day (Thursday, 28 April), will conclude with the Great Debate: “In chronic type B dissection, there is no place for false lumen embolisation.” Peter Mossop (Melbourne, Australia) and Jonathan Sobocinski (Lile, France) favour intervention in the true lumen and they will be opposed by Tilo Kölbel (Hamburg, Germany) and Fabrizio Fanelli (Rome, Italy) who are in favour of embolisation of the false lumen to thrombose it.
“The management of type B dissection has lingered with us for about five years. It will be interesting to see what the audience makes of this,” comments Greenhalgh.
The CX Thoracic Aortic Aneurysm Challenges Day will take place at the Charing Cross Symposium on Thursday 28 April – Upper Main Auditorium, Olympia Grand, London, UK
Click here to see the CX Interactive Main Programme – Thoracic Aortic Aneurysm Challenges
Click here to register
